글로벌 항균제 시장 – 2029년까지의 산업 동향 및 예측

글로벌 항균제 시장 분석 및 규모

최근 몇 년 동안 항균제 시장은 빠르게 성장할 것으로 예상됩니다. 성장 궤적의 변화는 주로 수요가 극적으로 증가한 COVID-19 팬데믹 이후 기업들이 생산량을 안정화했기 때문입니다. 코로나바이러스의 기하급수적 확산으로 전 세계 항균제 시장은 상당한 증가를 목격할 것으로 예상됩니다. 이에 더해 다양한 세균성 질병의 높은 유병률로 인해 시장에 항균제가 도입될 것입니다. 

• 항균제는 가장 효과적인 화학 요법 중 하나이며, 인간을 감염성 감염으로부터 보호하는 데 사용되었습니다. 미생물은 항균제에 의해 죽거나 느려집니다. 박테리아 , 바이러스, 원생동물, 곰팡이와 녹과 같은 균류는 미생물의 한 형태입니다.
• Data Bridge Market Research는 항균제 시장이 2021년에 395.6억 달러 규모였으며 2029년까지 607.1억 달러에 도달할 것으로 예상되며 2022년에서 2029년까지의 예측 기간 동안 5.50%의 CAGR을 기록할 것으로 분석했습니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

항균제 시장 동향

운전자

• 세균감염 유병률 증가

결핵, 호흡기 감염, 요로 감염(UTI), 피부 감염 및 기타 세균 감염의 유병률 증가는 글로벌 항균제 시장의 성장을 촉진할 것입니다.    

• 의료 인프라에 대한 투자 증가

항균제 시장의 성장률에 영향을 미치는 또 다른 중요한 요인은 의료 서비스 지출이 증가하고 있다는 점인데, 이는 인프라 개선에 도움이 됩니다.

또한, 인식을 확산하기 위한 공공 및 민간 기관의 이니셔티브 증가와 환자 치료를 개선하기 위한 정부 자금 증가는 항균제 시장을 확대할 요인입니다. 높은 가처분 소득과 앉아서 보내는 생활 방식과 같은 다른 요인은 항균제 시장의 성장률에 긍정적인 영향을 미칠 것입니다. 또한, 노인 인구 증가는 항균제 시장 확대로 이어질 것입니다. 의료 기술의 발전은 치료 시장의 성장률 확대로 이어질 주요 원동력으로 작용할 것입니다.

기회

• 공공 및 민간 기관의 R&D 투자 증가

The rise in the research and development activities and increasing investments by government and private organization will boost new opportunities for the market's growth rate.

Moreover, continuous economic development and introduction of blockbuster therapeutics will escalate the growth rate antimicrobials market in the future.

Restraints/Challenges Global Antimicrobials Market

However, high cost associated with the antimicrobials and lack of infrastructure in low-income countries will impede the growth rate of antimicrobials market. Additionally, side effects of antimicrobials will hinder the antimicrobials market growth. The lack of awareness and increasing demand for alternative medicines involving naturopathy and homeopathy will further challenge the market in the forecast period mentioned above.

This antimicrobials market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on antimicrobials market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Antimicrobials market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Antimicrobials Market

Since its emergence in December 2019, the COVID-19 virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. Due to the financial crisis and the delay in specialty healthcare delivery while prioritizing COVID-19-related treatments, healthcare systems around the world have been severely disrupted in the aftermath of the coronavirus pandemic. The COVID-19 had an impact on the global pharmaceutical supply chain, as well as the antimicrobials market. On the other hand, many antibiotics were initially used to treat COVID-19 and were widely prescribed and tested as a COVID-19 treatment.

Recent Development

• In October 2021, the cephalosporin antibiotics business of GSK has been acquired by Sandoz, a Novartis company. It now owns rights to three well-known products (Zinnat, Zinacef, and Fortum) in over 100 countries, solidifying its position as the world's premier antibiotics company.

Global Antimicrobials Market Scope

The antimicrobials market is segmented on the basis of type, origin, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Antibacterial
• Antifungal
• Antiviral
• Others

On the basis of type, the antimicrobials market is segmented into antibacterial, antifungal, antiviral and others. Antibacterial can be further segmented into macrolides, beta-lactams, quinolones and others.

Origin

• Natural
• Semi-Synthetic
• Synthetic

On the basis of origin, the antimicrobials market is segmented into natural, semi-synthetic and synthetic.

Dosage

• Powder
• Tablet
• Solution
• Liquid
• Others

On the basis of dosage, the antimicrobials market is segmented into powder, tablet, solution, liquid, and others.  

Route of Administration

• Oral
• Topical
• Parenteral
• Others

On the basis of route of administration, the antimicrobials market is segmented into oral, topical, parenteral and others.

End Users

• Clinic
• Hospital
• Others

On the basis of end-users, the antimicrobials market is segmented into clinic, hospital and others.

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

The antimicrobials market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Antimicrobials Market Regional Analysis/Insights

The antimicrobials market is analysed and market size insights and trends are provided by country, type, origin, dosage, route of administration, end-users and distribution channel as referenced above.

The countries covered in the antimicrobials market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the antimicrobials market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of major key players and technological advancement in this region.

Europe is estimated to be the second-largest growing region of antimicrobials market owing to the high investment in R&D activities and well-established healthcare infrastructure.

Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period due to the increasing prevalence of infectious diseases, rising investment in the healthcare sector and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Antimicrobials Market Share Analysis

The antimicrobials market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to antimicrobials market.

Some of the major players operating in the antimicrobials market are Abbott, AstraZeneca, Bristol-Myers Squibb Company, Eli Lilly and Company, Merck & Co., Inc., F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Mylan N.V., Aurobindo Pharma, Cipla Inc., Sun Pharmaceutical Industries Ltd, Amneal Pharmaceuticals LLC, Alembic Pharmaceuticals Limited, Lupin, Novartis AG, Zydus Cadila, Bausch Health Companies Inc., Johnson & Johnson Private Limited, Dr. Reddy’s Laboratories Ltd., and AbbVie Inc., among others.

Research Methodology : Global Antimicrobials Market

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석 및 추정됩니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭 다운하세요. DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 기본(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 이 외에도 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 회사 시장 점유율 분석, 측정 표준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의 사항을 드롭하여 업계 전문가에게 문의하세요  https://www.databridgemarketresearch.com/ko/speak-to-analyst/?dbmr=global-antibiotics-market

SKU-52994